
Share on:
Arcam received an order for five Arcam Q10 systems from Beijing AK Medical, a present customer in China. The systems will be used for volume production of orthopaedic implants.
Beijing AK Medical, an Arcam customer since 2010, announced in August its formal approval from the Chinese State Food and Drug Administration (CFDA) for EBM-manufactured implants. This was the first CFDA marketing approval for an additively manufactured orthopaedic implant.
Arcam Group provides Additive Manufacturing solutions for the production of metal components.
RELATED ARTICLES
AVNA Names Chip Harvill as Senior Business Development Executive
May 05 2025 , Julie A. Vetalice
Lincotek and Promimic Enter Strategic License Agreement
Apr 23 2025 , Julie A. Vetalice
Trump’s Tariffs Offer Opportunity for Supply Chain Improvement
Apr 23 2025 , BONEZONE Editors